These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 794419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA, COCHRANE CG, MUELLER-EBERHARD HJ.
    J Exp Med; 1965 Aug 01; 122(2):327-46. PubMed ID: 14316948
    [Abstract] [Full Text] [Related]

  • 5. Chemotactic factor produced by Candida albicans.
    Cutler JE.
    Infect Immun; 1977 Dec 01; 18(3):568-73. PubMed ID: 338483
    [Abstract] [Full Text] [Related]

  • 6. Experimental cutaneous candidiasis in rodents; II. Role of the stratum corneum barrier and serum complement as a mediator of a protective infalmmatory response.
    Ray TL, Wuepper KD.
    Arch Dermatol; 1978 Apr 01; 114(4):539-43. PubMed ID: 646364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
    Lukasser-Vogl E, Gruber A, Lass-Flörl C, Eder A, Høgåsen AK, Morgan BP, Dierich MP, Würzner R.
    FEMS Immunol Med Microbiol; 2000 May 01; 28(1):15-23. PubMed ID: 10767603
    [Abstract] [Full Text] [Related]

  • 9. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA, Klebanoff SJ.
    J Immunol; 1976 Oct 01; 117(4):1378-86. PubMed ID: 977954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
    Ruddy S, Austen KF, Goetzl EJ.
    J Clin Invest; 1975 Mar 01; 55(3):587-92. PubMed ID: 1167871
    [Abstract] [Full Text] [Related]

  • 15. Purification of a mannan from Candida albicans which activates serum complement.
    Ray TL, Hanson A, Ray LF, Wuepper KD.
    J Invest Dermatol; 1979 Oct 01; 73(4):269-74. PubMed ID: 383852
    [Abstract] [Full Text] [Related]

  • 16. [Reactivity of Candida albicans in the system of the alternative way of complement activation].
    Zaslavskaia MI, Makhrova TV, Maianskiĭ AN.
    Zh Mikrobiol Epidemiol Immunobiol; 2004 Oct 01; (5):80-4. PubMed ID: 15554320
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum-independent neutrophil chemotaxins in the yeast phase of Candida albicans.
    Brasch J, Schröder JM, Christophers E.
    Mycoses; 1991 Oct 01; 34(1-2):35-9. PubMed ID: 1922186
    [Abstract] [Full Text] [Related]

  • 19. Complement activation by cigarette smoke.
    Robbins RA, Nelson KJ, Gossman GL, Koyama S, Rennard SI.
    Am J Physiol; 1991 Apr 01; 260(4 Pt 1):L254-9. PubMed ID: 1902064
    [Abstract] [Full Text] [Related]

  • 20. Properdin: initiation of alternative complement pathway.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1975 Aug 01; 72(8):3220-4. PubMed ID: 1059108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.